Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B

被引：9
|
作者：
Yip, Terry C. F. [1 ]
Wong, Vincent Wai-Sun [1 ]
Tse, Yee-Kit [1 ]
Chan, Henry [1 ]
Wong, Grace Lai-Hung [1 ]
机构：
[1] Dept Med & Therapeut, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30227-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LBO-03
引用
收藏
页码：E128 / E128
页数：1
相关论文
共 50 条
  • [1] Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
    Liu, Hairong
    Shi, Yu
    Hayden, John C.
    Ryan, Paul M.
    Rahmani, Jamal
    Yu, Guangsheng
    [J]. LIVER CANCER, 2020, 9 (04) : 468 - 476
  • [2] Lower risk of hepatocellular carcinoma among patients with chronic hepatitis B treated with tenofovir than entecavir
    Young-Suk Lim
    [J]. Cancer Biology & Medicine, 2018, (S1) : 19 - 20
  • [3] Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis
    Yuan, Bao-Hong
    Li, Ru-Hong
    Huo, Rong-Rui
    Li, Min-Jun
    Papatheodoridis, George
    Zhong, Jian-Hong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (05) : 782 - 794
  • [4] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Zhang, Hao
    Zeng, Wenting
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 914 - 915
  • [5] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B Reply
    Choi, Jonggi
    Ko, Min Jung
    Lim, Young-Suk
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 916 - 917
  • [6] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?
    Kamal, Faisal
    Khan, Muhammad Ali
    [J]. GASTROENTEROLOGY, 2020, 158 (08) : 2311 - 2312
  • [7] OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDERGOING ENTECAVIR OR TENOFOVIR TREATMENT
    Lee, Chieh-Ju
    Su, Chien-Wei
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. HEPATOLOGY, 2019, 70 : 578A - 579A
  • [8] Use of tenofovir disoproxil fumarate is associated with a lower risk of hepatocellular carcinoma than entecavir in patients with chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    [J]. HEPATOMA RESEARCH, 2021, 7
  • [9] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    [J]. GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [10] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Reply
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    [J]. GASTROENTEROLOGY, 2020, 158 (08) : 2312 - 2313
12345